Biophotonic compositions and methods for providing biophotonic treatment

Patent metadata

Field	Value
Publication number	US-11723854-B2
Application number	US-202217743518-A
Country	US
Kind code	B2
Filing date	May 13, 2022
Priority date	Apr 20, 2012
Publication date	Aug 15, 2023
Grant date	Aug 15, 2023

Abstract

The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition. The biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.

First claim

What is claimed is:

1. A method for promoting skin rejuvenation comprising:
(a) topically applying on a target skin tissue an effective amount of a biophotonic composition comprising:
a first chromophore; and
a gelling agent present in the biophotonic composition in an amount sufficient to gel the biophotonic composition to render the biophotonic composition substantially resistant to leaching such that less than 15% by weight of the total chromophore amount leaches out of the biophotonic composition as measured by:
placing a 2 mm thick layer of the biophotonic composition onto a top surface of a 2.4-3 cm diameter polycarbonate membrane with a thickness of 10 microns and a pore size of 3 microns;
contacting a bottom surface of the polycarbonate membrane with a phosphate saline buffer solution contained in a receptor compartment; and
after a treatment time of 5 minutes at room temperature and pressure, measuring the chromophore content in the receptor compartment; and

wherein the first chromophore is dispersed throughout the biophotonic composition; and
wherein the biophotonic composition is photoactivatable and when photoactivated, the biophotonic composition emits light having a wavelength ranging from about 490 nm to about 800 nm; and
(b) illuminating said biophotonic composition with light having a wavelength that overlaps with an absorption spectrum of the first chromophore.

2. The method according to claim 1 , wherein said biophotonic composition is illuminated for about 1 minute to about 30 minutes, preferably for less than 20 minutes, less than 15 minutes, less than 10 minutes or about 5 minutes.

3. The method according to claim 1 , wherein said biophotonic composition is illuminated with visible non-coherent light.

4. The method according to claim 1 , wherein the light emitted by the biophotonic composition has a power density of between about 0.005 mW/cm 2 to about 10 mW/cm 2 .

5. The method according to claim 1 , wherein said biophotonic composition is translucent.

6. The method of claim 5 , wherein the translucency comprises at least 20%, 30%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 85%, 90%, 95% or 100% transmittance of light through a 2 mm thick composition.

7. The method according to claim 1 , wherein the first chromophore is Eosin Y, Eosin B, Erythrosin B, Fluorescein, Rose Bengal or Phloxin B.

8. The method according to claim 1 , wherein the first chromophore is present in an amount of about 0.001% to about 40% by weight of the total composition.

9. The method according to claim 1 , wherein the gelling agent is at least one of glycerin, propylene glycol, a high molecular weight cross-linked polyacrylic acid polymer, or a hydrophilic polymer.

10. The method according to claim 1 , wherein the gelling agent is a vinyl polymer, a polyoxyethylene-polyoxypropylene copolymer, a poly(ethylene oxide), or an acrylamide polymer, or salts thereof.

11. The method according to claim 1 , wherein the biophotonic composition further comprises an oxygen-releasing agent.

12. The method according to claim 11 , wherein the oxygen-releasing agent is hydrogen peroxide, carbamide peroxide, benzoyl peroxide, peroxy acid, an alkali metal peroxide, an alkali metal percarbonate, peroxyacetic acid, or an alkali metal perborate.

13. The method according to claim 1 , wherein said biophotonic composition further comprises a humectant.

14. The method of claim 13 , wherein the humectant is glycerine.

15. The method according to claim 1 , wherein said biophotonic composition further comprises a second chromophore.

16. The method according to claim 15 , wherein the first chromophore has an emission spectrum that overlaps at least 20% with an absorption spectrum of the second chromophore.

17. The method according to claim 15 , wherein the first chromophore is Eosin Y, and the second chromophore is one or more of Fluorescein, Phloxine B or Erythrosine B.

18. The method according to claim 15 , wherein the first chromophore is Fluorescein, and the second chromophore is Eosin Y.

19. The method according to claim 1 , wherein the biophotonic composition has a viscosity ranging from about 10 000 cP and about 100 000 cP.

Assignees

• Klox Tech Inc
• Fle Int S R L

Inventors

• Piergallini Remigio
• Loupis Nikolaos
• Rastogi Shipra

Classifications

• C09K11/06

  containing organic luminescent materials · CPC title

• C09K11/02

  Use of particular materials as binders, particle coatings or suspension media therefor · CPC title

• A61Q19/08

  Anti-ageing preparations · CPC title

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

• A61P1/02

  Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title